Let me know when the data is updated again

Casa Saba, S.A. de C.V.

Summary of sales of medicines and medical supplies

210 purchase as supplier for a total of 328.2 millones (328,159,967.076 ) between 2008 and 2010.

Annual evolution of purchase
Procedure type
Top buyers



Largest purchase



Total overcost

Overcost in MXN

156,646.1 pesos mexicanos

Overcost in %

122.9 %

Top products
Product Purchases Total amount Overcost in MXN Overcost in % Period
EFAVIRENZ 40 30.1 millones MXN 12,285.4 MXN 21.3 % 2009 - 2010
RALTEGRAVIR 18 292,035.1 MXN 1,258.3 MXN 0.205 % 2009 - 2010
MONTELUKAST 12 48.4 millones MXN 19,919 MXN 35.4 % 2009 - 2010
DIGOXINA 10 195,599.5 MXN 7,406.5 MXN 5.29 % 2009 - 2010
INSULINA LISPRO LISPRO PROTAMINA 8 12,012.8 MXN 3,842 MXN 47 % 2010 - 2010
LEVOMEPROMAZINA 6 16,323.6 MXN 14,568 MXN 829.8 % 2009 - 2009
INSULINA LISPRO LISPRO PROTAMINA 5 10,043.3 MXN 1,715.1 MXN 27.7 % 2009 - 2010
MONTELUKAST 5 35.5 millones MXN 0 MXN 0 % 2009 - 2010
MOMETASONA 4 4,002.4 MXN 2,168.5 MXN 118.2 % 2010 - 2010

Location

Country

México

GENERAL INFORMATION

Alternative names

  • CASA SABA, S. A. DE C. V.
  • CASA SABA, S.A. DE C.V.
  • CASA SABA S.A DE C.V.
  • CASA SABA S.A. DE C.V.
  • CASA SABA, S.A DE C.V
  • CASA SABA S.A DE C.V
  • CASA SABA S.A. DE.C.V.
  • CASA SABA S.A. DE .V.

Entity type

profit

Identifiers

RFC: CSA980102UV4

Date updated in QQW

24 de enero de 2019

Organization responsible for the import

PODER